Company intelligence / Profile preview
Reverb Therapeutics
Vancouver, British Columbia, Canadareverbtx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Reverb Therapeutics is a preclinical-stage biotech developing bispecific antibody therapies that redirect and amplify endogenous cytokines for targeted immune modulation. Their lead program targets cancers with poor response to current therapies, with proof-of-concept established in vivo. The company plans to enter clinical trials within two years and is also initiating programs for autoimmune diseases. Early preclinical data are described as "extremely exciting" by investors, but no human clinical results have been reported yet.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Bispecific antibodies
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Multiple Myeloma Research Foundation/Myeloma Investment Fund (investment & collaboration on multiple myeloma)Amplitude Ventures (lead investor/strategic support)
Beyond the preview
Go deeper on Reverb Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Reverb Therapeutics.